Cyberknife Precision Radiation Delivery System for Tumors of the Spine

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00185666

Enrollment

200

Registered

2005-09-16

Start date

2002-05-31

Completion date

2006-05-31

Last updated

2010-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain (Nervous System) Cancers, Spinal Cord Cancer

Brief summary

The purpose of this study is to determine the usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions.

Interventions

PROCEDUREStereotactic radiosurgery

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

5 Years to No maximum

Healthy volunteers

Inclusion criteria

- Intra-axial, extra-axial, or vertebral spinal lesion * Age \> 5 * Histologic confirmation of malignant primary lesion or radiographic diagnosis of benign or vascular spinal lesion * No rapidly deteriorating symptoms of spinal cord compression * No instability of the spine * Life expectancy \> 6 months

Exclusion criteria

- Patients without tumors of the spine * Patients younger than 5 years old

Design outcomes

Primary

Measure	Time frame
Usefulness of Cyberknife precision radiation in eliminating or preventing the further growth of spinal tumors and lesions	completed

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026